Caxton Associates (New York)’s Clarus CLAR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-13,561
Closed -$376K 541
2021
Q4
$376K Sell
13,561
-12,015
-47% -$332K 0.04% 349
2021
Q3
$656K Buy
25,576
+9,339
+58% +$258K 0.07% 157
2021
Q2
$417K Buy
+16,237
New +$346K 0.05% 221
2020
Q4
Sell
-27,256
Closed -$385K 166
2020
Q3
$385K Buy
27,256
+5,883
+28% +$73.5K 0.04% 149
2020
Q2
$247K Buy
+21,373
New +$217K 0.02% 318
2019
Q3
Sell
-13,382
Closed -$192K 408
2019
Q2
$192K Buy
+13,382
New +$178K 0.02% 365

Other funds holding CLAR

Caxton Associates (New York)'s CLAR Position: Q1 2022 in Review

Caxton Associates (New York) sold out of Clarus (CLAR) in Q1 2022, closing a stake of 13,561 shares — an estimated $376K sold.

Caxton Associates (New York) first reported a position in CLAR in Q2 2019 and held it in 6 quarters. The position peaked at $656K in Q3 2021. 117 funds tracked by Wall St. Rank hold CLAR as of Q1 2022.

  • Caxton Associates (New York) reported no remaining Clarus position as of Q1 2022 after selling out during the quarter.
  • Caxton Associates (New York) sold 13,561 Clarus shares in Q1 2022, an estimated $376K.
  • Caxton Associates (New York) first reported a position in Clarus in Q2 2019 and held it in 6 quarters.
  • Caxton Associates (New York)'s Clarus position peaked at $656K in Q3 2021.
  • 117 funds tracked by Wall St. Rank held Clarus as of Q1 2022.

Based on Caxton Associates (New York)'s 13F filing for Q1 2022, filed 16 May 2022.